Slingshot members are tracking this corporate initiative:
Lilly (LLY) Completes Acquisition of Dermira (DERM)
Do you think this event is important to the companies below? How will it affect their stock price?
Lilly's tender offer for all outstanding shares of common stock of Dermira, at a price of $18.75 per share in cash, expired as scheduled at one minute past 11:59 p.m., Eastern time, on February 19, 2020. As of the expiration of the tender offer, 40,926,025 shares of Dermira common stock were validly tendered and not properly withdrawn, representing approximately 74.8 percent of the shares of Dermira common stock outstanding, and have been accepted for payment under the terms of the tender offer. Following completion of the tender offer, Lilly completed the acquisition of Dermira through the previously-planned second-step merger.
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Feb 20, 2020 Projected Implementation: Q1, 2020 Relevance Tracked Until: Q2, 2020
Don’t see a project related to the strategic initiative you care about?
Related Keywords Lebrikizumab